Healthcare provider profile · identity verified

Marcel Wiggers, MD

Allopathic & Osteopathic Physicians|Internal Medicine · GRANTS PASS, OR · NPI 1780649939

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Marcel Wiggers, MD received $25.20 in general payments during 2025 across 1 reported records.

Tactile Systems Technology Inc accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$25.20

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Tactile Systems Technology Inc	Unresolved — no canonical attribution shown	$25.20	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$25.20	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Flexitouch Plus Normalized: flexitouch plus	Device	Tactile Systems Technology Inc	$25.20	1	2025
Source payment records 2025-01-06 · Tactile Systems Technology Inc · $25.20 · Open Payments source
Nimbl Normalized: nimbl	Device	Tactile Systems Technology Inc	$25.20	1	2025
Source payment records 2025-01-06 · Tactile Systems Technology Inc · $25.20 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	517	172
Amlodipine Besylate	Amlodipine Besylate	326	107
Lisinopril	Lisinopril	323	114
Atorvastatin Calcium	Atorvastatin Calcium	321	122
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	320	84
Omeprazole	Omeprazole	305	95
Losartan Potassium	Losartan Potassium	273	89
Metoprolol Succinate	Metoprolol Succinate	202	66
Gabapentin	Gabapentin	201	69
Trazodone Hcl	Trazodone Hcl	142	49
Prednisone	Prednisone	138	95
Rosuvastatin Calcium	Rosuvastatin Calcium	134	46
Tamsulosin Hcl	Tamsulosin Hcl	124	46
Metoprolol Tartrate	Metoprolol Tartrate	122	37
Meloxicam	Meloxicam	114	45
Eliquis	Apixaban	110	30
Metformin Hcl	Metformin Hcl	108	40
Potassium Chloride	Potassium Chloride	108	36
Furosemide	Furosemide	107	39
Alprazolam	Alprazolam	103	25
Estradiol	Estradiol	102	34
Simvastatin	Simvastatin	95	34
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	94	37
Escitalopram Oxalate	Escitalopram Oxalate	91	22
Zolpidem Tartrate	Zolpidem Tartrate	85	26
Fluticasone Propionate	Fluticasone Propionate	84	37
Sertraline Hcl	Sertraline Hcl	83	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	78	21
Pantoprazole Sodium	Pantoprazole Sodium	75	28
Lovastatin	Lovastatin	74	23
Azithromycin	Azithromycin	73	64
Atenolol	Atenolol	72	24
Hydrochlorothiazide	Hydrochlorothiazide	70	28
Lorazepam	Lorazepam	70	20
Diazepam	Diazepam	67	suppressed
Famotidine	Famotidine	66	19
Propranolol Hcl	Propranolol Hcl	63	20
Albuterol Sulfate Hfa	Albuterol Sulfate	62	37
Warfarin Sodium	Warfarin Sodium	62	18
Carvedilol	Carvedilol	58	20
Clopidogrel	Clopidogrel Bisulfate	56	22
Allopurinol	Allopurinol	53	22
Acetaminophen-Codeine	Acetaminophen With Codeine	51	suppressed
Metformin Hcl Er	Metformin Hcl	50	20
Citalopram Hbr	Citalopram Hydrobromide	49	14
Spironolactone	Spironolactone	49	18
Xarelto	Rivaroxaban	49	11
Duloxetine Hcl	Duloxetine Hcl	48	19
Glimepiride	Glimepiride	47	18
Ventolin Hfa	Albuterol Sulfate	46	11
Bupropion Xl	Bupropion Hcl	44	16
Celecoxib	Celecoxib	44	14
Alendronate Sodium	Alendronate Sodium	42	14
Finasteride	Finasteride	40	13
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	19
Pioglitazone Hcl	Pioglitazone Hcl	39	15
Pravastatin Sodium	Pravastatin Sodium	39	13
Donepezil Hcl	Donepezil Hcl	37	12
Doxycycline Hyclate	Doxycycline Hyclate	37	27
Clonazepam	Clonazepam	36	suppressed
Ezetimibe	Ezetimibe	35	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	32
Levetiracetam	Levetiracetam	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Pregabalin	Pregabalin	33	11
Triamcinolone Acetonide	Triamcinolone Acetonide	33	27
Baclofen	Baclofen	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	11
Amoxicillin	Amoxicillin	30	25
Buspirone Hcl	Buspirone Hcl	30	suppressed
Cholestyramine	Cholestyramine (With Sugar)	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Ondansetron Odt	Ondansetron	26	14
Memantine Hcl	Memantine Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	21
Venlafaxine Hcl Er	Venlafaxine Hcl	25	11
Prazosin Hcl	Prazosin Hcl	24	suppressed
Nystatin	Nystatin	23	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Glipizide	Glipizide	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Cephalexin	Cephalexin	19	18
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Digoxin	Digoxin	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Nitroglycerin	Nitroglycerin	18	11
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Methadone Hcl	Methadone Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Temazepam	Temazepam	14	suppressed
Xtampza Er	Oxycodone Myristate	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Mupirocin	Mupirocin	13	13
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$25.20 · 1 records	Tactile Systems Technology Inc	Flexitouch Plus, Nimbl	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error